Lv3
280 积分 2024-03-11 加入
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia
1天前
已完结
Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations
6天前
已完结
Molecular Diversity and Associated Phenotypic Spectrum of GermlineCBLMutations
6天前
已完结
Anchored Multiplex PCR Enables NGS-Based Detection of FLT3-ITDs
1个月前
已关闭
A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
1个月前
已完结
Ultrasensitive Detection of FLT3-ITD Mutations via Primer Competition Enhanced Mutant Accumulation
1个月前
已完结
The molecular mechanisms behind activation of FLT3 in acute myeloid leukemia and resistance to therapy by selective inhibitors
1个月前
已完结
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML
8个月前
已完结
RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia
8个月前
已完结
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes
9个月前
已完结
皖公网安备34019202002308
